NRA-PRUCALOPRIDE DIN 02550385
Health Canada record
| Active ingredient(s) | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 2 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A06AX05 PRUCALOPRIDE |
| Original market date | 28-Oct-2024 |
| Current status date | 28-Oct-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
Nora Pharma Inc — licence 3-002506, currently licensed, last inspection rating C (2022-11-29).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02491591 | APO-PRUCALOPRIDE | APOTEX INC | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 1 MG | Marketed |
| 02491605 | APO-PRUCALOPRIDE | APOTEX INC | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 2 MG | Marketed |
| 02493497 | JAMP PRUCALOPRIDE | JAMP PHARMA CORPORATION | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 2 MG | Marketed |
| 02493489 | JAMP PRUCALOPRIDE | JAMP PHARMA CORPORATION | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 1 MG | Marketed |
| 02550377 | NRA-PRUCALOPRIDE | NORA PHARMA INC | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 1 MG | Marketed |
| 02559013 | PRUCALOPRIDE | SANIS HEALTH INC | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 2 MG | Marketed |
| 02559005 | PRUCALOPRIDE | SANIS HEALTH INC | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 1 MG | Marketed |
| 02377020 | RESOTRAN | AMDIPHARM LIMITED | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 2 MG | Marketed |
| 02377012 | RESOTRAN | AMDIPHARM LIMITED | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 1 MG | Marketed |
| 02499959 | PMS-PRUCALOPRIDE | PHARMASCIENCE INC | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 2 MG | Cancelled Pre Market |
| 02499940 | PMS-PRUCALOPRIDE | PHARMASCIENCE INC | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 1 MG | Cancelled Pre Market |